Quarterly Call Option Transactions in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during . The information is specifically focused on institutions that hold call options of Ultragenyx Pharmaceutical Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2022 | 155,800 | 60,800 | 216,600 | 40,000 | 0 | 40,000 | 176,600 | |
| Q4 2022 | 38,500 | 77,700 | 116,200 | 149,300 | 0 | 149,300 | -33,100 | |
| Q1 2023 | 10,000 | 8,800 | 18,800 | 130,600 | 6,300 | 136,900 | -118,100 | |
| Q2 2023 | 79,400 | 28,000 | 107,400 | 25,100 | 0 | 25,100 | 82,300 | |
| Q3 2023 | 251,500 | 6,400 | 257,900 | 77,200 | 0 | 77,200 | 180,700 | |
| Q4 2023 | 61,800 | 74,300 | 136,100 | 216,900 | 0 | 216,900 | -80,800 | |
| Q1 2024 | 26,800 | 337,700 | 364,500 | 45,500 | 0 | 45,500 | 319,000 | |
| Q2 2024 | 231,900 | 2,400 | 234,300 | 7,400 | 0 | 7,400 | 226,900 | |
| Q3 2024 | 40,300 | 193,500 | 233,800 | 15,000 | 0 | 15,000 | 218,800 | |
| Q4 2024 | 135,100 | 241,758 | 376,858 | 160,100 | 0 | 160,100 | 216,758 | |
| Q1 2025 | 397,200 | 237,100 | 634,300 | 112,400 | 0 | 112,400 | 521,900 | |
| Q2 2025 | 2,245,900 | 559,600 | 2,805,500 | 177,400 | 0 | 177,400 | 2,628,100 | |
| Q3 2025 | 419,900 | 245,900 | 665,800 | 907,500 | 0 | 907,500 | -241,700 | |